Publication

2012 - CRC Press, Boca Raton, Florida

Language

English

Word Count

63,000 words, Guess

Page Count

252 pages

Identifiers

Classifications

  • LCCRC267 .G744 2012

Description

The third edition provides a concise, nontechnical, and thoroughly up-to-date review of methods and issues related to cancer clinical trials. The authors emphasize the importance of proper study design, analysis, and data management and identify the pitfalls inherent in these processes. In addition, the book has been restructured to have separate chapters and expanded discussions on general clinical trials issues, and issues specific to Phases I, II, and III. New sections cover innovations in Phase I designs, randomized Phase II designs, and overcoming the challenges of array data. Although this book focuses on cancer trials, the same issues and concepts are important in any clinical setting. As always, the authors use clear, lucid prose and a multitude of real-world examples to convey the principles of successful trials without the need for a strong statistics or mathematics background.

Subjects

Series Statement

  • Chapman & Hall/CRC Interdisciplinary statistics series

Similar Books

Reader Reviews

No reviews yet for this book.

Be the first to share your thoughts!